<SEC-DOCUMENT>9999999995-14-002571-index.html : 20140821
<SEC-HEADER>9999999995-14-002571.hdr.sgml : 20140821
<ACCEPTANCE-DATETIME>20140821001525
ACCESSION NUMBER:		9999999995-14-002571
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20140820
DATE AS OF CHANGE:		20140821
EFFECTIVENESS DATE:		20140820

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celsus Therapeutics Plc.
		CENTRAL INDEX KEY:			0001541157
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981034922
		STATE OF INCORPORATION:			X0

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-198107
		FILM NUMBER:		141056229

	BUSINESS ADDRESS:	
		STREET 1:		53 DAVIES STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1K 5JH
		BUSINESS PHONE:		646-878-0804

	MAIL ADDRESS:	
		STREET 1:		C/O MARK COHEN, CHAIRMAN, PEARL COHEN
		STREET 2:		1500 BROADWAY, 12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Morria Biopharmaceuticals PLC
		DATE OF NAME CHANGE:	20120201
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>